125 related articles for article (PubMed ID: 8259039)
1. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
Tsukahara K; Kanai S; Ohta M; Kitani K
Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
[TBL] [Abstract][Full Text] [Related]
2. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of hydrophilic bile acids on bile acid hepatotoxicity in the rat.
Kitani K
Ital J Gastroenterol; 1995 Sep; 27(7):366-71. PubMed ID: 8563008
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat.
Kitani K; Ohta M; Kanai S
Am J Physiol; 1985 Apr; 248(4 Pt 1):G407-17. PubMed ID: 2984943
[TBL] [Abstract][Full Text] [Related]
5. Tauro beta-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
Kanai S; Ohta M; Kitani K; Sato Y
Life Sci; 1990; 47(26):2421-8. PubMed ID: 2263167
[TBL] [Abstract][Full Text] [Related]
6. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
Kanai S; Kitani K; Sato Y
J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
[TBL] [Abstract][Full Text] [Related]
7. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
9. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
Queneau PE; Bertault-Perès P; Mesdjian E; Durand A; Montet JC
Transplantation; 1993 Sep; 56(3):530-4. PubMed ID: 8212145
[TBL] [Abstract][Full Text] [Related]
10. The mutant Eisai hyperbilirubinemic rat is resistant to bile acid-induced cholestasis and cytotoxicity.
Hoshino M; Hayakawa T; Hirano A; Kamiya Y; Ohiwa T; Tanaka A; Kumai T; Inagaki T; Miyaji M; Takeuchi T
Hepatology; 1994 Oct; 20(4 Pt 1):932-9. PubMed ID: 7927235
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
12. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
Kanai S; Kitani K; Sato Y
Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transport of bile acid and effect of conjugation.
Kitani K
Ital J Gastroenterol; 1995 Jun; 27(5):270-6. PubMed ID: 8541581
[TBL] [Abstract][Full Text] [Related]
14. Differing transport maxima values for taurine-conjugated bile salts in rats and hamsters.
Kitani K; Kanai S; Ohta M; Sato Y
Am J Physiol; 1986 Dec; 251(6 Pt 1):G852-8. PubMed ID: 3789151
[TBL] [Abstract][Full Text] [Related]
15. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Heuman DM; Mills AS; McCall J; Hylemon PB; Pandak WM; Vlahcevic ZR
Gastroenterology; 1991 Jan; 100(1):203-11. PubMed ID: 1983822
[TBL] [Abstract][Full Text] [Related]
17. Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster.
Gurantz D; Hofmann AF
Am J Physiol; 1984 Dec; 247(6 Pt 1):G736-48. PubMed ID: 6507626
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
Accatino L; Figueroa C; Pizarro M; Solís N
J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
[TBL] [Abstract][Full Text] [Related]
19. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
[TBL] [Abstract][Full Text] [Related]
20. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
Takikawa H; Minagawa K; Sano N; Yamanaka M
Dig Dis Sci; 1993 Aug; 38(8):1543-8. PubMed ID: 8344113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
